Clinical Trial Update: A Study to Evaluate the Effectiveness of Long-acting (LA) Cabotegravir (CAB) + Rilpivirine (RPV) LA When Given to Participants With Detectable HIV-1 [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating the effectiveness of long-acting cabotegravir plus long-acting rilpivirine in participants with detectable HIV-1 is currently recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Apretude (cabotegravir) (cabotegravir)
• RPV-LA (rilpivirine long-acting) (rilpivirine)

Snippet

Sponsor: ViiV Healthcare | Conditions: HIV Infections | Phase 3 | Status: RECRUITING